High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer-Reference-Cited by-同舟云学术

High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer

Published:2006-04 Issue:2 Volume:13 Page:172-178
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Sawaki Masataka,Ito Yoshinori,Akiyama Futoshi,Tokudome Nahomi,Horii Rie,Mizunuma Nobuyuki,Takahashi Shunji,Horikoshi Noboru,Imai Tsuneo,Nakao Akimasa,Kasumi Fujio,Sakamoto Goi,Hatake Kiyohiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.springerlink.com/index/pdf/10.2325/jbcs.13.172

Reference17 articles.

1. Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD: Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975–1992.Cancer 82:2366–2372, 1998.

2. Liauw SL, Benda RK, Morris CG, Mendenhall NP: Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.Cancer 100:920–928, 2004.

3. Turpin E, Biéche I, Bertheau P, Plassa LF, Lerebours F, Roquancourt de A, Olivi M, Espié M, Marty M, Lidereau R, Vidaud M, Thé de H: Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.Oncogene 21:7593–7597, 2002.

4. Haagensen CD: Inflammatory carcinoma. In: Haagensen CD. Diseases of the Breast, 2nd ed, Philadelphia; PA, W.B. Saunders, pp576–584, 1971.

5. Bonnier P, Charpin C, Lejeune C, Romain S, Tubiana N, Beedassy B, Martin PM, Serment H, Piana L: Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?Int J Cancer 62:382–385, 1995.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis;International Review of Cell and Molecular Biology;2024

2. Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls;The Breast;2023-12

3. Extra-Small Gold Nanospheres Decorated With a Thiol Functionalized Biodegradable and Biocompatible Linear Polyamidoamine as Nanovectors of Anticancer Molecules;Frontiers in Bioengineering and Biotechnology;2020-03-04

4. Inflammatory Breast Cancer;The Breast;2018

5. Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients;Breast Cancer Research and Treatment;2017-03-07